Market Closed -
Sao Paulo
04:07:45 2024-05-10 pm EDT
|
5-day change
|
1st Jan Change
|
30.62
BRL
|
+1.16%
|
|
+14.17%
|
+6.47%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
132,664
|
88,380
|
66,643
|
64,842
|
69,052
|
-
|
-
|
Enterprise Value (EV)
1 |
146,263
|
108,214
|
74,687
|
71,208
|
76,988
|
75,805
|
77,879
|
P/E ratio
|
311
x
|
56.3
x
|
55.9
x
|
31.8
x
|
21.9
x
|
18.1
x
|
13.5
x
|
Yield
|
0.08%
|
0.73%
|
1.18%
|
1.26%
|
1.19%
|
1.73%
|
2.16%
|
Capitalization / Revenue
|
9.46
x
|
4.34
x
|
2.9
x
|
1.39
x
|
1.29
x
|
1.19
x
|
1.04
x
|
EV / Revenue
|
10.4
x
|
5.31
x
|
3.25
x
|
1.53
x
|
1.44
x
|
1.31
x
|
1.18
x
|
EV / EBITDA
|
46
x
|
19
x
|
12.6
x
|
9.68
x
|
9.58
x
|
8.1
x
|
7.07
x
|
EV / FCF
|
-143
x
|
-48.1
x
|
-64.5
x
|
-34.3
x
|
23.6
x
|
19.1
x
|
15.9
x
|
FCF Yield
|
-0.7%
|
-2.08%
|
-1.55%
|
-2.91%
|
4.23%
|
5.23%
|
6.31%
|
Price to Book
|
9.75
x
|
6.51
x
|
3.06
x
|
2.88
x
|
2.69
x
|
2.45
x
|
2.3
x
|
Nbr of stocks (in thousands)
|
1,942,366
|
1,971,453
|
2,252,958
|
2,254,607
|
2,255,119
|
-
|
-
|
Reference price
2 |
68.30
|
44.83
|
29.58
|
28.76
|
30.62
|
30.62
|
30.62
|
Announcement Date
|
2/24/21
|
3/29/22
|
3/27/23
|
3/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
14,029
|
20,382
|
22,987
|
46,509
|
53,624
|
58,075
|
66,269
|
EBITDA
1 |
3,179
|
5,696
|
5,907
|
7,354
|
8,038
|
9,363
|
11,021
|
EBIT
1 |
1,637
|
3,668
|
3,899
|
4,491
|
5,947
|
7,258
|
9,092
|
Operating Margin
|
11.67%
|
18%
|
16.96%
|
9.66%
|
11.09%
|
12.5%
|
13.72%
|
Earnings before Tax (EBT)
1 |
483.5
|
2,033
|
1,325
|
2,674
|
4,214
|
5,318
|
6,830
|
Net income
1 |
428.3
|
1,575
|
1,195
|
2,095
|
3,155
|
3,833
|
4,858
|
Net margin
|
3.05%
|
7.73%
|
5.2%
|
4.5%
|
5.88%
|
6.6%
|
7.33%
|
EPS
2 |
0.2198
|
0.7968
|
0.5290
|
0.9051
|
1.399
|
1.688
|
2.265
|
Free Cash Flow
1 |
-1,022
|
-2,248
|
-1,158
|
-2,074
|
3,259
|
3,962
|
4,911
|
FCF margin
|
-7.29%
|
-11.03%
|
-5.04%
|
-4.46%
|
6.08%
|
6.82%
|
7.41%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
40.54%
|
42.32%
|
44.56%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
103.3%
|
103.37%
|
101.09%
|
Dividend per Share
2 |
0.0539
|
0.3268
|
0.3495
|
0.3637
|
0.3642
|
0.5307
|
0.6612
|
Announcement Date
|
2/24/21
|
3/29/22
|
3/27/23
|
3/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
5,136
|
5,373
|
5,799
|
6,063
|
5,752
|
4,915
|
11,679
|
11,812
|
11,812
|
12,195
|
14,333
|
14,757
|
14,538
|
EBITDA
1 |
1,285
|
1,317
|
1,580
|
1,657
|
1,353
|
1,347
|
1,615
|
1,912
|
1,772
|
2,087
|
2,272
|
2,316
|
2,239
|
EBIT
1 |
924.1
|
793.5
|
846.2
|
1,163
|
878.5
|
866.3
|
1,122
|
1,414
|
1,088
|
1,685
|
1,528
|
1,567
|
1,480
|
Operating Margin
|
17.99%
|
14.77%
|
14.59%
|
19.18%
|
15.27%
|
17.63%
|
9.61%
|
11.97%
|
9.21%
|
13.82%
|
10.66%
|
10.62%
|
10.18%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
327.5
|
616.4
|
980.7
|
749.4
|
1,013
|
1,105
|
1,147
|
1,066
|
Net income
1 |
406.4
|
-
|
-
|
375.3
|
215.1
|
287.4
|
408.5
|
753.8
|
644.8
|
804.6
|
785.1
|
849.9
|
782.4
|
Net margin
|
7.91%
|
-
|
-
|
6.19%
|
3.74%
|
5.85%
|
3.5%
|
6.38%
|
5.46%
|
6.6%
|
5.48%
|
5.76%
|
5.38%
|
EPS
2 |
0.2056
|
0.1064
|
0.1714
|
0.1899
|
0.0610
|
0.1272
|
0.1812
|
0.3344
|
0.2621
|
0.3570
|
0.3301
|
0.3692
|
0.3535
|
Dividend per Share
2 |
0.0944
|
0.1969
|
0.0500
|
-
|
0.0800
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.2733
|
Announcement Date
|
3/29/22
|
5/13/22
|
8/15/22
|
11/9/22
|
3/27/23
|
5/16/23
|
8/9/23
|
11/8/23
|
3/27/24
|
5/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
13,600
|
19,834
|
8,044
|
6,365
|
7,936
|
6,754
|
8,828
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.278
x
|
3.482
x
|
1.362
x
|
0.8655
x
|
0.9873
x
|
0.7213
x
|
0.801
x
|
Free Cash Flow
1 |
-1,022
|
-2,248
|
-1,158
|
-2,074
|
3,259
|
3,962
|
4,911
|
ROE (net income / shareholders' equity)
|
4.55%
|
11.6%
|
6.75%
|
9.52%
|
12.9%
|
15%
|
17.9%
|
ROA (Net income/ Total Assets)
|
1.19%
|
3.21%
|
-
|
2.37%
|
3.09%
|
4.02%
|
5.03%
|
Assets
1 |
36,143
|
49,069
|
-
|
88,510
|
101,969
|
95,392
|
96,625
|
Book Value Per Share
2 |
7.010
|
6.890
|
9.680
|
10.00
|
11.40
|
12.50
|
13.30
|
Cash Flow per Share
2 |
-0.0400
|
-0.0600
|
0.5800
|
0.1800
|
1.540
|
-
|
-
|
Capex
1 |
945
|
2,127
|
2,476
|
2,470
|
2,555
|
2,090
|
1,883
|
Capex / Sales
|
6.74%
|
10.43%
|
10.77%
|
5.31%
|
4.76%
|
3.6%
|
2.84%
|
Announcement Date
|
2/24/21
|
3/29/22
|
3/27/23
|
3/27/24
|
-
|
-
|
-
|
Last Close Price
30.62
BRL Average target price
34.27
BRL Spread / Average Target +11.93% Consensus |
1st Jan change
|
Capi.
|
---|
| +6.47% | 13.4B | | +20.68% | 85.55B | | -29.31% | 70.07B | | +9.23% | 29.06B | | -8.63% | 17.51B | | +2.14% | 17.39B | | +0.39% | 15.38B | | +68.09% | 12.87B | | +6.43% | 12.77B | | +68.23% | 12.42B |
Other Healthcare Facilities & Services
|